changing times in dlbcl and practicalities of antibody therapy
Published 3 years ago • 80 plays • Length 56:15Download video MP4
Download video MP3
Similar videos
-
56:44
treatment innovation in dlbcl: real-world insight on integrating antibodies and cellular therapy
-
1:24:16
perspectives on novel antibody platforms in dlbcl
-
35:13
reaching the next level of myeloma patient care: antibody therapy and novel mechanisms of action
-
0:46
dlbcl prognosis & management in front-line settings #oncology #lungcancer #cancer #2023
-
2:52
anti-cd19 monoclonal antibody therapy in dlbcl
-
20:10
lymphomas in 2024 changing standards of care and challenging paradigms elizabeth brem, md from uci
-
1:01
the current landscape of antibody-based therapies in r/r dlbcl
-
38:51
monoclonal antibodies and their role in dlbcl treatment
-
3:01
how the treatment of dlbcl and fl are changing in the uk
-
3:49
the challenges in developing bispecific antibodies for non-hodgkin lymphoma
-
2:08
the current and future role of bispecifics in r/r dlbcl: epcoritamab, glofitamab & more
-
4:46
treatment of r/r dlbcl: cd19-targeted monoclonal antibodies
-
1:28:51
antibody therapy in acute leukemia: clinical considerations in conjunction with hsct
-
1:08:35
innovative therapy in multiple myeloma: monoclonal antibodies and bcma and non-bcma options
-
54:13
treatment options for dlbcl
-
1:04:53
breaking therapeutic barriers with novel antibodies in rrmm
-
21:56
what's new in the approach to dlbcl upfront and in the relapsed setting beyond car t
-
2:44
polarix study: frontline therapy in dlbcl
-
24:57
how to treat diffuse large b-cell lymphoma (dlbcl) - dr. carla casulo